MA40369A - Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil - Google Patents

Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil

Info

Publication number
MA40369A
MA40369A MA040369A MA40369A MA40369A MA 40369 A MA40369 A MA 40369A MA 040369 A MA040369 A MA 040369A MA 40369 A MA40369 A MA 40369A MA 40369 A MA40369 A MA 40369A
Authority
MA
Morocco
Prior art keywords
foods
drugs
preparation
cistanche tubulosa
ocular cells
Prior art date
Application number
MA040369A
Other languages
English (en)
Inventor
Chin-Wen Lee
Original Assignee
Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou filed Critical Sinphar Tian Li Pharmaceutical Co Ltd Hangzhou
Publication of MA40369A publication Critical patent/MA40369A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/64—Orobanchaceae (Broom-rape family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne des applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection des cellules de l'œil. Ledit extrait permet aussi d'obtenir un médicament ou produit permettant de prévenir les maladies de l'œil ou retarder la progression des maladies de l'œil.
MA040369A 2014-07-03 2015-07-03 Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil MA40369A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462020409P 2014-07-03 2014-07-03

Publications (1)

Publication Number Publication Date
MA40369A true MA40369A (fr) 2017-06-21

Family

ID=55016238

Family Applications (1)

Application Number Title Priority Date Filing Date
MA040369A MA40369A (fr) 2014-07-03 2015-07-03 Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil

Country Status (10)

Country Link
US (2) US20160000847A1 (fr)
EP (1) EP3181143B8 (fr)
JP (1) JP6573961B2 (fr)
KR (1) KR20170039160A (fr)
CN (2) CN105232640A (fr)
MA (1) MA40369A (fr)
MY (1) MY192535A (fr)
RU (1) RU2688939C2 (fr)
TW (1) TWI650131B (fr)
WO (1) WO2016000663A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6599505B2 (ja) 2018-04-27 2019-10-30 株式会社ダイヘン アークエンド調整装置、溶接システム、アークエンド調整方法及びコンピュータプログラム
TWI830221B (zh) * 2021-05-06 2024-01-21 杏國新藥股份有限公司 緩解乾眼症的方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001034169A1 (fr) * 1999-11-11 2001-05-17 Dietrich Paper Utilisation d'un extrait de plantago lanceolata
CN1268341C (zh) * 2003-03-04 2006-08-09 杏辉天力（杭州）药业有限公司 来源于管花肉苁蓉的含有苯乙醇苷的制剂及其制备方法和用途
JP4936507B2 (ja) * 2006-01-18 2012-05-23 学校法人近畿大学 カンカニクジュヨウの抽出物より得られる強壮剤又は強精剤、配糖体化合物及びそれらの用途
CN100475189C (zh) * 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
JP2008239505A (ja) * 2007-03-26 2008-10-09 Oriza Yuka Kk 神経芽細胞増殖促進剤及び神経突起伸展剤
JP5264107B2 (ja) * 2007-06-01 2013-08-14 小林製薬株式会社 抗酸化作用を有する組成物
CN101331906A (zh) * 2007-06-28 2008-12-31 杏辉天力（杭州）药业有限公司 含苁蓉成分和咖啡成分的饮品
CN101322750B (zh) * 2008-06-04 2012-01-04 *** 管花肉苁蓉提取物的新用途
TWI486162B (zh) * 2010-06-16 2015-06-01 Sinphar Pharmaceutical Co Ltd 異類葉升麻苷或其醫藥學上可接受之鹽於抑制澱粉樣β肽生成、累積或聚集、以及製備預防或治療澱粉樣β肽相關疾病或狀況的藥物之用途
WO2012158591A1 (fr) * 2011-05-18 2012-11-22 The Research Foundation Of State University Of New York Produits et méthodes anti-blépharite
JP5969738B2 (ja) * 2011-07-25 2016-08-17 丸善製薬株式会社 抗糖化作用剤
CA2859227C (fr) * 2011-12-16 2019-01-22 Sinphar Tian-Li Pharmaceutical Co., Ltd. (Hangzhou) Composition medicale pour prevenir ou traiter des etats ou maladies associes au peptide ? amyloide
CN102813753B (zh) * 2012-05-22 2014-02-26 孟令刚 含有苁蓉或锁阳与菊花、牛磺酸、番茄红素、叶黄素、β-胡萝卜素组合的组合物
JP6151003B2 (ja) * 2012-10-26 2017-06-21 学校法人近畿大学 カンカニクジュヨウから得られる抗糖尿病剤、ヒト又は動物用医薬および機能性食品
US9339522B2 (en) * 2013-05-30 2016-05-17 Sinphar Pharmaceutical Co., Ltd. Method for regulating blood glucose level
CN103896997B (zh) * 2014-04-14 2016-07-06 青海伊纳维康生物科技有限公司 一种肉苁蓉中毛蕊花糖苷的分离纯化方法

Also Published As

Publication number Publication date
MY192535A (en) 2022-08-26
CN112870258A (zh) 2021-06-01
RU2017102407A (ru) 2018-08-03
JP6573961B2 (ja) 2019-09-11
US20160000847A1 (en) 2016-01-07
RU2688939C2 (ru) 2019-05-23
EP3181143B8 (fr) 2020-11-18
EP3181143A1 (fr) 2017-06-21
TW201601740A (zh) 2016-01-16
US10967029B2 (en) 2021-04-06
WO2016000663A1 (fr) 2016-01-07
RU2017102407A3 (fr) 2018-08-03
TWI650131B (zh) 2019-02-11
EP3181143A4 (fr) 2018-05-16
EP3181143B1 (fr) 2020-09-23
KR20170039160A (ko) 2017-04-10
CN105232640A (zh) 2016-01-13
US20180117109A1 (en) 2018-05-03
JP2017531614A (ja) 2017-10-26

Similar Documents

Publication Publication Date Title
CA2956871C (fr) Composes actifs envers des bromodomaines
HK1223628A1 (zh) β- 新的 -酮- β-烷基膽烷酸衍生物在製備奧貝膽酸以及其在醫藥領域的用途
EP3413851A4 (fr) Kit d'injection oculaire, conditionnement et procédés d'utilisation
EP3177732A4 (fr) Compositions et procédés pour le traitement de maladies et états pathologiques ophthalmiques
IL285258A (en) Retinal ganglion cells and their progenitor cells
EP3167046A4 (fr) Production et cryopréservation de cellules fucosylées à usage thérapeutique
EP3188688A4 (fr) Méthodes et compositions biocompatibles pour obtenir une libération prolongée de médicament dans l' il
EP3124741A4 (fr) Agent de soutènement auto-suspendu, sa préparation et son utilisation
EP3102291A4 (fr) Progranuline (pgrn) et ses dérivés pour le diagnostic et le traitement de maladies lysosomales
EP3154533A4 (fr) Procédés d'anesthésie de tissu nerveux dans la voie du nerf trijumeau et utilisations médicales de ceux-ci
AU356247S (en) Coffee maker
EP3220912A4 (fr) Combinaisons d'un inhibiteur de tlr et d'un inhibiteur de la tyrosine kinase de bruton
EP3397752A4 (fr) Cellules du noeud sinusal et de purkinje induites issues de cellules souches adultes
EP3281539A4 (fr) Article de lingerie féminine et moyen de fixation
EP3721890A4 (fr) Préparation médicamenteuse ophtalmique et ses utilisations
EP3246036A4 (fr) Medicament pour ameliorer l'etat de grossesse, et son utilisation
EP3238758A4 (fr) Hémodiafiltre et dispositif d'hémodiafiltration
EP3167893A4 (fr) Compositions pharmaceutiques contenant un extrait de spirulina maxima en tant que principe actif pour la prévention et le traitement de maladies rétiniennes
HK1243327A1 (zh) 包含螺旋藻和棕櫚酰基乙醇酰胺和/或其鹽或藥用上可接受衍生物的組合及其製劑，用於預防和/或治療過度活化的組織病症
MA40369A (fr) Applications de l'extrait de cistanche tubulosa dans la préparation d'un médicament ou produit de protection les cellules de l'œil
EP3197466A4 (fr) Association de kynurénine et de cellules présentatrices d'antigène (cpa) en tant qu'agent thérapeutique, et méthodes d'utilisation de cette dernière dans la modulation immunitaire
EP3212280A4 (fr) Procédé d'adaptation aux acouphènes chez des patients à ic et à itc
EP3094330A4 (fr) Traitement de la maladie de crohn au moyen de faibles doses de laquinimod
HRP20182167T1 (hr) Derivati benzilhidroksida, njihova priprava i njihova terapeutska uporaba
EP3384900A4 (fr) Forme galénique stabilisé d'un conjugué d'éthydronate avec le citrabine et son utilisation